We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase 3 Study of Dexpramipexole in ALS (EMPOWER)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01281189
Recruitment Status : Completed
First Posted : January 21, 2011
Last Update Posted : December 15, 2017
Sponsor:
Information provided by (Responsible Party):